|
| Exchange Disseminated Time 13/05/2016 20:07:41 | Sun Pharmaceutical Industries Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, interalia, to transact the following business:
- To consider and approve standalone and consolidated Audited Financial Results of the Company for the year ended March 31, 2016.
- To consider recommendation of dividend for the year ended March 31, 2016 subject to the approval of the shareholders at the ensuing Annual General Meeting.
Further, window closure for trading by designated persons as per Insider Trading Rules of the Company will be from May 19, 2016 to June 01, 2016 (both days inclusive). |
|
|